Understanding POM121L4P: A Potential Drug Target and Biomarker

Target Name: POM121L4P

NCBI ID: G266697

POM121L4P

Other Name(s): POM121L1 | POM121 transmembrane nucleoporin like 4, pseudogene | POM121L1P

Understanding POM121L4P: A Potential Drug Target and Biomarker

POM121L4P is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a key regulator of cell proliferation and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Despite its widespread expression, little is known about POM121L4P and its function in the body. In this article, we will explore the potential implications of POM121L4P as a drug target and the research that has been done to study its properties.

POM121L4P as a Drug Target

POM121L4P has been identified as a potential drug target due to its involvement in a number of cellular processes that are important for disease progression. One of the key functions of POM121L4P is its role in cell proliferation. POM121L4P is a transcription factor that is involved in the regulation of gene expression, and it has been shown to play a role in the proliferation of various cell types.

In addition to its role in cell proliferation, POM121L4P is also involved in the regulation of cell survival. Studies have shown that POM121L4P plays a role in the regulation of apoptosis, a process by which cells die and are removed from the body. This is important for the development and progression of many diseases, including cancer.

Another function of POM121L4P is its role in the regulation of cell signaling pathways. POM121L4P has been shown to play a role in the regulation of various signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. These pathways are involved in the regulation of cellular processes that are important for many cellular processes, including cell growth, differentiation, and survival.

POM121L4P as a Biomarker

POM121L4P has also been identified as a potential biomarker for a number of diseases. For example, studies have shown that POM121L4P is expressed in various tissues of the brain and that it is involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases. This suggests that POM121L4P may be a useful biomarker for the diagnosis and treatment of such diseases.

In addition to its potential as a drug target, POM121L4P has also been identified as a potential biomarker for cancer. Studies have shown that POM121L4P is expressed in various tissues of the body, including those of cancer cells. This suggests that POM121L4P may be a useful biomarker for the diagnosis and treatment of cancer.

Conclusion

POM121L4P is a protein that is involved in a number of cellular processes that are important for disease progression. As a result, it has been identified as a potential drug target and a potential biomarker for a number of diseases. Further research is needed to fully understand the functions of POM121L4P and its potential as a drug and biomarker.

Protein Name: POM121 Transmembrane Nucleoporin Like 4, Pseudogene

The "POM121L4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POM121L4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets